Pediatric endocrinopathies are commonly diagnosed and monitored by measuring hormones of the hypothalamic-pituitary-gonadal axis. Because growth and development can markedly influence normal circulating concentrations of fertility hormones, accurate reference intervals established on the basis of a healthy, nonhospitalized pediatric population and that reflect age-, gender-, and pubertal stage-specific changes are essential for test result interpretation.
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Hormones of the hypothalamic-pituitary-gonadal (HPG) 5 axis are important markers for evaluation of multiple pediatric endocrinopathies. For example, the gonadotropins luteinizing hormone (LH) and folliclestimulating hormone (FSH) regulate gonadal activity and are important in the diagnosis of pituitary disorders, problems associated with the reproductive organs, and both early and delayed puberty. In addition, concentrations of the gonadal hormones estradiol, testosterone, and progesterone are essential markers of sexual development and differentiation and contribute to the maintenance of female or male phenotypes. As such, serum concentrations of these biomarkers are tightly regulated throughout childhood (1) (2) (3) . Abnormal concentrations in children and adolescents may be indicative of ambiguous genitalia in infants, hypogonadism, precocious puberty, oligoamenorrhea, hirsutism in females, feminization in males, and, rarely, estrogen-or androgen-producing neoplasms. Sex hormone-binding globulin (SHBG) is a transporter for both estradiol and testosterone in blood and regulates availability of both hormones to their target tissues during childhood and adolescence. Given the important role of these hormones in sexual development, cir-culating concentrations can differ between the neonatal period, early childhood, prepubertal years, and puberty, reflecting developmental and maturation processes of various organs and tissues (2, 4 -6 ) . In addition, important differences are also found between the hormone concentrations observed in boys and girls (5) (6) (7) (8) . As such, it is critically important that pediatric reference intervals are established that reflect these changes (i.e., partitioned according to age, sex, and developmental stage) to aid in differentiating between healthy children and those in need of further medical follow-up.
Over the last 10 years, immunoassay-based measurements of endocrine markers have improved substantially, and new technological advances have resulted in very sensitive and robust methods with increased specificity (9, 10 ) . However, many existing reference intervals are based on older methods (7 ) and are therefore outdated. Furthermore, most studies that have calculated pediatric reference intervals for fertility hormones are based on very small groups of children (1 ) or hospitalized patients (7, 8 ) , an approach that has been questioned by some (11 ) . As a result, reference intervals for many endocrine markers are not well defined.
To overcome the above limitations, we used samples collected from a cohort of healthy children and adolescents (from birth to 18 years old) recruited as part of the CALIPER (Canadian Laboratory Initiative in Pediatric Reference Intervals) study (12 ) to determine comprehensive reference intervals for the fertility hormones estradiol, progesterone, LH, FSH, testosterone, SHBG, and prolactin. In addition, Tanner stagespecific reference intervals were determined in a subset of children ages 9 -15 years. We show that concentrations of the 7 fertility hormones display variable patterns across both sex and age, necessitating multiple reference intervals to appropriately cover the period from infancy to early adulthood.
Materials and Methods

PARTICIPANT RECRUITMENT AND SAMPLE COLLECTION
Participant recruitment and sample collection was conducted as previously described (12 ) . Briefly, healthy children (n ϭ 1234) from birth to 18 years of age were recruited to participate in the CALIPER study. The study was approved by the Institutional Review Board at the Hospital for Sick Children, Toronto, Canada. All samples from participants older than 1 year were collected from healthy children in the community. Participation in this study included completion of a short questionnaire, written informed consent, and donation of a blood sample. Participants with a history of chronic illness, metabolic disease, acute illness within the previous month, or use of prescribed medication over the previous 2 weeks were excluded from the study. Demographic data collected included diet, exercise status, ethnicity, and body mass index. For newborn infants younger than 1 year, samples were collected from apparently healthy/metabolically stable neonates and children in hospital maternity wards and select outpatient clinics (e.g., dentistry, orthopedics).
Tanner staging was performed via self-assessment of consenting CALIPER study participants ages 9 -15 years. Tanner staging is the 5-stage standard clinical system for describing normal pubertal development developed by Marshall and Tanner (13, 14 ) , with Tanner stage I being prepubertal and Tanner stage V being adult. It is one of the primary tools used to follow progress through puberty. Each stage represents the extent of pubic hair growth and breast development in girls and the extent of pubic hair growth and genitalia development in boys. CALIPER study participants were given diagrams of Tanner stages I to V and were asked to provide Tanner scores by self-assessment (15 ) .
Blood samples were collected in serum separator tubes (BD). All collected samples were centrifuged, separated, and aliquoted within 4 h of collection, and serum aliquots were kept frozen at Ϫ80°C until testing. All samples analyzed were matched by age, sex, and ethnicity to generate equivalent groups for comparison and ensure an ethnically diverse group.
SAMPLE ANALYSIS
We measured serum estradiol, testosterone (second generation), progesterone, SHBG, prolactin, FSH, and LH concentrations on the Abbott Architect i2000SR system using chemiluminescence. We analyzed the samples in batches over a 7-month period. Analytical methods were controlled according to the manufacturer's instructions regarding preventive maintenance, function checks, calibration, and QC. Information about the analytical parameters of the Architect assays, calibration, and traceability is provided in Table 1 . Samples for the reference intervals were analyzed only when all analytical parameters were acceptable.
STATISTICAL ANALYSIS AND REFERENCE INTERVAL
DETERMINATION
Age-and sex-specific reference intervals. Data were analyzed in accordance with Clinical Laboratory Standards Institute (CLSI) C28-A3 guidelines (16 ) . We performed statistical analysis using Microsoft Excel and R software as outlined in Fig. 1 . Briefly, the data were visually inspected using scatter and distribution plots. If the data were not skewed, then we removed outliers using the Tukey test (17 ) . Conversely, if data were found to be skewed, outliers were identified and re-moved with an adjusted Tukey test that multiplied the interquartile range by a factor using the data's calculated medcouple (18 ) . Partitions were decided on the basis of trends observed within the distribution plots and then statistically evaluated using the Harris and Boyd test (19 ) , which uses the standard deviation and a variant of the z-statistic between 2 groups to determine whether to partition. We used the nonparametric rank method to calculate the reference interval for partitions with a sample size of at least 120 participants; we also calculated the 90% CI around the upper and lower limits for each partition. For analytes with partitions con- Conversion from conventional units to SI units: estradiol, pg/mL ϫ 3.67 ϭ pmol/L; progesterone, ng/dL ϫ 0.0318 ϭ nmol/L; FSH, mIU/mL ϫ 1.00 ϭ IU/L; LH, mIU/mL ϫ 1.00 ϭ IU/L; testosterone, ng/dL ϫ 0.0347 ϭ nmol/L; SHBG, no conversion; prolactin, ng/mL ϫ 21 ϭ mIU/L. b QC material for estradiol, progesterone, FSH, LH, SHBG, and prolactin was obtained from BIO-RAD clinical diagnostics. The QC material for testosterone shown in this table was obtained from Abbott Diagnostics; however, additional QC material from BIO-RAD clinical diagnostics was also assayed to supplement precision data for higher concentrations of testosterone (data not shown). taining at least 40 but fewer than 120 participants, we used the robust statistical method developed by Horn and Pesce (20 ) to calculate the reference interval and 90% CI around the lower and upper reference limits for each sex-and age-specific partition. For reference intervals where the lower limit of the reference interval was at the limit of detection, only the upper reference limit is presented. As the study population consisted of whites, east Asians, and south Asians, we also assessed differences in analyte concentrations between these 3 ethnic groups as previously described (12 ) .
Tanner stage-specific reference intervals. To further explore the effect of sexual development on reference intervals, we analyzed Tanner stage data in a subset of girls and boys aged 9 -15 years. Outliers were identified with the Tukey or adjusted Tukey test for analytes in each Tanner stage individually. Owing to the small sample size in each Tanner stage (ranging between 18 and 67 data points), we used the robust method of Horn and Pesce (20 ) to calculate the reference interval and 90% CIs for each analyte.
Results
Samples from 1234 male and female participants ages birth to 18 years were used to calculate age-and sexspecific reference intervals. A subset from this population for whom self-reported Tanner stage data were available was used to calculate Tanner stage-specific reference intervals. The age-and sex-specific pediatric reference intervals for the 7 fertility hormones (serum estradiol, progesterone, FSH, LH, testosterone, SHBG, and prolactin) are provided in Table 2 . Supplemental tables expressing the same reference intervals in SI units are available with the online version of this article at http://www.clinchem.org/content/vol59/issue8 (see Supplemental Table 1 ). All 7 hormones demonstrated a complex pattern of change in analyte concentrations over time. Estradiol, progesterone, FSH, LH, and testosterone also showed marked differences in concentrations between boys and girls, as expected ( Fig. 2 , A-F). Interestingly, all hormones required partitioning within the first year of life, and LH, prolactin, and SHBG required additional stratification within that time period (Table 2 ). LH and prolactin displayed higher concentrations in both boys and girls during the neonatal period, and concentrations subsequently began to decline by 3 months and 30 days, respectively (Fig. 2, D and H) . FSH was also increased during the first year of life, though this was much more pronounced in girls (Fig. 2C) . SHBG concentrations exhibited a wide range in values in early infancy, as evidenced by the broad reference interval for both boys and girls between 30 days and 1 year. Concentrations then began to decrease with age (Fig. 2G) . Also of note, modest differences in analyte concentrations were observed among ethnic groups for FSH (boys only, P ϭ 0.047) and SHBG (P ϭ 0.014). The small sample size for some ethnic groups, however, prohibited calculation of ethnicity-specific reference intervals. Ethnic differences were not observed for any other analyte investigated.
Concentrations of both progesterone and testosterone were increased during the neonatal period, although the magnitude of this increase was different between sexes (Fig. 2, B and E/F, respectively). Testosterone was significantly higher in boys (Fig. 2E ) compared with girls ( Fig. 2F) during the early infancy period (Ͻ6 months), whereas concentrations reached similar values in both sexes during the childhood and prepubertal years (ages 1-11). As expected, a significant increase in testosterone was evident in boys Ͼ11 years, and concentrations continued to increase until early adulthood (Fig. 2E) . A very small increase was evident in girls Ͼ13 years old (Fig. 2F) . As a result of these sex-specific fluctuations in testosterone concentration, 6 age partitions were required for boys, Data analysis was performed according to CLSI C28-A3 guidelines.
whereas only 4 were required for girls (Table 2 ). In contrast, progesterone was higher in girls during the first year of life and again during adolescence. Unlike those 2 hormones, estradiol did not demonstrate significant sex differences during infancy. Therefore, 1 reference interval was considered suitable for both sexes between the ages of 15 days and 1 year. A small spike was evident in both sexes during the first year of life, followed by a plateau lasting until puberty (girls, age 9 years; boys, age 11 years) ( Fig. 2A) . Concentrations in girls then began to increase significantly, reaching a peak concentration at 14 -18 years of age. Six age a Conversion from conventional units to SI units: estradiol, pg/mL ϫ 3.67 ϭ pmol/L; progesterone, ng/dL ϫ 0.0318 ϭ nmol/L; FSH, mIU/mL ϫ 1.00 ϭ IU/L; LH, mIU/mL ϫ 1.00 ϭ IU/L; testosterone, ng/dL ϫ 0.0347 ϭ nmol/L; SHBG, no conversion; prolactin, ng/mL ϫ 21 ϭ mIU/L. b Menstrual cycle data were not available, therefore these reference intervals should be interpreted with caution. Use of adult reference intervals for females ages 15-19 may be more appropriate. c NA, not applicable. When the lower limit of the reference interval was at the limit of detection, no value is given and instead, the reference interval should be reported as Ͻ upper reference limit. d See the disclosure section at the end of this article for important information on the reference intervals for prolactin.
Fig. 2. Scatter plots showing changes in analyte concentration with age for boys (blue) and girls (pink).
A, estradiol; B, progesterone; C, FSH; D, LH; E, testosterone in boys (inset, all subjects); F, testosterone in girls; G, SHBG; H, prolactin.
partitions were required for estradiol reference intervals in girls.
In addition to stratifying by age and sex, reference intervals for the 7 fertility hormones were also calculated on the basis of self-reported Tanner stage and are shown in Table 3 (for SI units, see online Supplemental  Table 2 ). Table 4 shows the mean age and age range for the 5 Tanner stages as reported by participants in this study. Each Tanner stage is composed of a wide range of ages for both boys and girls. Not surprisingly, all 7 hormones demonstrated Tanner stage reference intervals that were similar to those determined by sex and age partitioning, albeit with some notable differences. As expected, concentrations of estradiol, progesterone, FSH, and LH in girls showed a pattern of marked increase between Tanner stages I and V, whereas the val- a Conversion from conventional units to SI units: estradiol, pg/mL ϫ 3.67 ϭ pmol/L; progesterone, ng/dL ϫ 0.0318 ϭ nmol/L; FSH, mIU/mL ϫ 1.00 ϭ IU/L; LH, mIU/mL ϫ 1.00 ϭ IU/L; testosterone, ng/dL ϫ 0.0347 ϭ nmol/L; SHBG, no conversion; prolactin, ng/mL ϫ 21 ϭ mIU/L. b Menstrual cycle data were not available, therefore these reference intervals should be interpreted with caution. Use of adult reference intervals for females ages 15-19 may be more appropriate. c NA, not applicable. When the lower limit of the reference interval was at the limit of detection, no value is given and instead, the reference interval should be reported as Ͻ upper reference limit. d See the disclosure section at the end of this article for important information on the reference intervals for prolactin.
ues for boys increased to a lesser extent. The opposite was seen for testosterone. Concentrations were significantly increased across Tanner stages in boys (Tanner I to V), whereas girls demonstrated only a modest increase. SHBG showed a similar pattern to what was observed using the age-and sex-specific reference ranges. Differences in patterns were also seen in prolactin, whose concentration in boys continued to increase throughout all Tanner stages, whereas the concentration in girls remained relatively stable.
Discussion
The present study is part of the CALIPER initiative, a project aimed at addressing critical gaps in pediatric reference intervals. Most of the fertility hormones studied required some degree of age, sex, and Tanner stage partitioning. The only exception was prolactin, for which gender differences were not observed. Although more common in adulthood compared to childhood, suspected hyperprolactinemia is the main indication for prolactin measurement. In most cases, pituitary adenomas are responsible for the increased secretion of this hormone and, therefore, serum prolactin measurement should be included in all cases of suspected pituitary disease (21, 22 ) . The finding in the present study that sex partitioning is not required for prolactin reference intervals is in agreement with others (4, 23 ) . Specifically, Aldrimer et al. (4 ) found no between-sex differences in prolactin in 694 healthy children from Sweden. In contrast, Soldin et al. (7 ) demonstrated a small difference in prolactin concentration between boys and girls, especially those younger than 2 years, although that study was based on hospitalized patients. Also of interest, only 3 agedependent reference intervals were required to cover the span from birth to 18 years in our cohort. Prolactin concentrations were significantly higher during the neonatal period. The surge in prolactin in the first 30 days of life has been well documented by others (24 ) and is believed to play a role in fetal breast development (25 ) . The source of this surge is believed to be fetal in origin and not maternal as is often suggested (25 ) . Prolactin concentrations stabilized after this period, requiring only 1 reference interval from 1 to 18 years of age. Prolactin concentrations were not found to be significantly different across Tanner stages in girls, suggesting that age-specific reference intervals are adequate for this hormone. In boys, however, the upper reference limit progressively increased with increasing Tanner stages, indicating that reference intervals partitioned solely by age may not be suitable.
The remaining 6 fertility hormones required several age-and sex-stratified groupings, resulting in multiple reference interval partitions from birth to 18 years of age. We found testosterone to be increased in the first 6 months of life for boys. This has been previously reported by many others (1, 3, 6 ) and is thought to be a result of the early activity of testicular steroidogenesis in a special population of Leydig cells present only during the fetal period (26 ) . This group of cells is responsible for the androgen-induced differentiation of male genitalia and disappears shortly after birth (26 ) . Notably, fetal Leydig cells are morphologically and functionally distinct from adult cells (26 ) . Girls also experienced a surge in testosterone during the first year of life, although to a much smaller extent than boys. Testosterone concentrations remained low in both sexes until puberty, when concentrations in boys began to increase, a finding that has been well documented in other studies (1, 3, 6 ) . Three partitions were required to cover the ages of 13-18 years in boys, which reflects the tight regulation and important role testosterone plays in development of secondary sexual characteristics during the pubertal years. Reference intervals also were significantly different according to Tanner stage, with serum testosterone in boys reaching adult concentrations by Tanner stages IV-V. Of note, testosterone immunoassays have suffered from poor sensitivity in the past, limiting clinical utility in children. With the advent of more sensitive assays involving liquid chromatography/tandem mass spectrometry (LC-MS/MS), laboratories can now obtain reliable values at lower concentrations. Interestingly, the testosterone reference intervals determined in this study are similar to those obtained from a LC-MS/MS testosterone method recently developed in our laboratory (27 ) .
SHBG demonstrated a pattern opposite that of testosterone, with lower concentrations observed during the pubertal periods and higher concentrations found Unlike testosterone, only a relatively small spike in estradiol was evident in the neonatal period; furthermore, the magnitude of this increase was similar between the 2 sexes. As a result, one partition was considered suitable for both boys and girls Ͻ1 year of age. Although some have reported higher concentrations of estradiol during the first 2 weeks of life (5 ), we did not have a sufficiently large sample size within this age range to investigate this issue. In girls, estradiol began to increase at the age of 9 years and, similar to testosterone in boys, required 4 age partitions to cover the ages of 9 -18 years to reflect the development of their secondary sexual characteristics during this period. In this regard, estradiol is most commonly used in adolescents in the differential diagnosis of precocious and delayed puberty in girls and, to a lesser extent, in boys (28 ) . A similar trend was evident from the Tanner stage-specific reference intervals in girls. Interestingly, comparable reference intervals for both age/sex and Tanner stage partitions were recently reported (2 ) .
In line with the above results, FSH and LH were markedly increased during the first year of life and during adolescence. Sex partitioning was required for FSH reference intervals during infancy, as the concentration in girls was higher than in boys. The opposite was true of LH, for which the reference interval for boys was higher than that for girls during the same time period. Similar findings have been reported by others (7, 8, 29 ) . The surge of both LH and FSH during the neonatal and early infancy period is accompanied by increases in both testosterone and estradiol, as mentioned above. It is believed that this transient activation of the HPG axis plays an important function in postnatal gonadal development in both boys and girls (30, 31 ) , although the mechanism surrounding this is not clearly understood. As expected and demonstrated by others (7, 8 ) , a second surge in the concentrations of both of these hormones was evident during adolescence. In the study by Soldin et al. (8 ) , LH continued to rise among girls ages 11-18 years, whereas LH stayed constant in pubertal boys. This is consistent with our findings; 4 age partitions were required for girls ages 10 -18 years to accommodate the increasing hormone concentrations, whereas LH remained stable from 10 to 16 years in boys.
Although we present important information regarding pediatric reference intervals for 7 fertility hormones, our study also has limitations. The number of children included in some partitions was quite small and, therefore, our data may not be indicative of trends in the general population. Specifically, testosterone is known to exhibit dynamic changes during the first 6 months of life, a trend that was not evident in our study. The number of samples included within this age range was quite small, and therefore studies involving a larger number of infants ages 0 -6 months are required. In addition, others have reported significant fluctuations in testosterone concentration throughout the day, particularly in pubertal boys. To assess the effect of diurnal variation on testosterone values during puberty, we statistically evaluated the influence of collection time in our dataset; however, no significant effect was observed. Again, this may be due to the small sample size in some partitions. This limitation of small group sizes was also true for the puberty-specific reference intervals, for which Tanner stage data were available in only a small number of individuals. Future studies are warranted to investigate Tanner stage-specific reference intervals in larger cohorts. In addition, conclusions regarding LH, FSH, estradiol, and progesterone reference intervals in postmenarchal girls may be difficult to establish, as information regarding the phase of menstrual cycle (i.e., follicular, ovulation, or luteal phase) was not available, and it is well known that concentrations of these hormones vary widely throughout the menstrual cycle. Variation is also observed in the concentrations of these hormones in the year or two leading up to menarche. For young women aged 15-19 years, use of adult reference intervals may be more appropriate. It is also important to point out that the reference intervals from this new database will need to be validated in local populations; furthermore, these reference intervals are valid only for assays on the Abbott platform and will need to be validated for other immunoassay platforms as recommended by CLSI. The complete database used to calculate the reference intervals is available as an online Supplemental Database file so that each laboratory may analyze the data by use of other partitions or criteria.
In conclusion, we report sex-, age-, and Tanner stage-specific reference intervals for 7 fertility hormones including estradiol, progesterone, FSH, LH, testosterone, SHBG, and prolactin, in healthy children ages birth to 18 years old as part of the CALIPER initiative. Higher concentrations of estradiol, progesterone, FSH, LH, testosterone, and prolactin were observed early in infancy, necessitating separate reference intervals within the first year of life. Although most of these hormones demonstrated fairly stable concentrations throughout childhood, marked increases often were observed in both sexes during pubertal development, requiring multiple age partitions. In particular, the concentrations of estradiol, progesterone, LH, FSH, and testosterone were found to increase in a sexspecific manner after puberty, whereas SHBG decreased, likely reflecting developmental changes and maturation of the HPG axis. The complex pattern of change observed for these fertility hormones underscores the importance of generating detailed reference intervals on the basis of large, diverse populations to allow for clinically accurate and physiologically relevant interpretation of patient results.
